For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Product Information
Phase Detail
Biosep SEC-s2000
BioSep SEC-s2000 SEC/ GFC phase is well suited for biogeneric aggregate, peptide therapeutics, PEGylated peptides, PEGylated small proteins

Biosep SEC-s2000

BioSep SEC-s2000 SEC/GFC phase has an exclusion range of:

  • 1,000 - 300,000 Da (Native)
  • 200 - 75,000 Da (0.5% SDS)
  • 500 - 100,000 Da (6M GnHCl)

Particle Size
5
Recommended Use
Ideal for biogeneric aggregate applications, peptide therapeutics, small proteins, PEGylated peptides, and PEGylated small proteins.

Biosep SEC-s2000 Documents

Biosep SEC-s2000 Documents

Showing 1-4 of 4 results
Type unfold_moreDocument Title unfold_more
Brochures BioSep GFC/SEC Brochure
Brochures United States Pharmacopeia (USP) Allowable Adjustments Guide
Technical Notes PEGylated Proteins by GFC (TN-1048)
Technical Notes PEGylated Proteins by Reversed Phase HPLC (TN-1046)
Document Title
BioSep GFC/SEC Brochure
United States Pharmacopeia (USP) Allowable Adjustments Guide
PEGylated Proteins by GFC (TN-1048)
PEGylated Proteins by Reversed Phase HPLC (TN-1046)